Zacks Research Issues Positive Outlook for Itron Earnings

Itron, Inc. (NASDAQ:ITRI - Free Report) - Stock analysts at Zacks Research raised their Q2 2025 EPS estimates for shares of Itron in a report issued on Thursday, May 22nd. Zacks Research analyst R. Department now forecasts that the scientific and technical instruments company will earn $1.27 per share for the quarter, up from their previous estimate of $1.22. The consensus estimate for Itron's current full-year earnings is $5.33 per share. Zacks Research also issued estimates for Itron's FY2025 earnings at $5.36 EPS, Q1 2027 earnings at $1.64 EPS and FY2027 earnings at $6.99 EPS.

Other research analysts have also issued research reports about the stock. Canaccord Genuity Group increased their price target on shares of Itron from $130.00 to $132.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Guggenheim reiterated a "buy" rating and issued a $133.00 target price on shares of Itron in a research note on Thursday, April 17th. Piper Sandler lowered their target price on shares of Itron from $124.00 to $121.00 and set a "neutral" rating on the stock in a research note on Monday, May 5th. Oppenheimer raised their price target on shares of Itron from $124.00 to $131.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. Finally, Wall Street Zen raised shares of Itron from a "hold" rating to a "buy" rating in a report on Saturday. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $127.36.

Itron Stock Up 2.5%

Shares of ITRI traded up $2.87 during mid-day trading on Monday, hitting $115.50. 820,113 shares of the company's stock were exchanged, compared to its average volume of 575,855. The firm has a fifty day moving average of $106.44 and a two-hundred day moving average of $107.77. Itron has a twelve month low of $90.11 and a twelve month high of $124.90. The stock has a market cap of $5.27 billion, a price-to-earnings ratio of 23.67, a P/E/G ratio of 0.81 and a beta of 1.31. The company has a quick ratio of 2.83, a current ratio of 3.36 and a debt-to-equity ratio of 0.91.

Itron (NASDAQ:ITRI - Get Free Report) last released its earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.30 by $0.22. Itron had a net margin of 9.37% and a return on equity of 19.03%. The company had revenue of $607.15 million during the quarter, compared to the consensus estimate of $608.86 million. During the same quarter in the prior year, the firm earned $1.24 EPS. The company's revenue was up .6% compared to the same quarter last year.

Insider Activity at Itron

In other Itron news, Director Mary C. Hemmingsen sold 750 shares of the business's stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $107.27, for a total value of $80,452.50. Following the completion of the transaction, the director now directly owns 5,630 shares of the company's stock, valued at approximately $603,930.10. The trade was a 11.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.45% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Itron

Institutional investors have recently modified their holdings of the stock. Invesco Ltd. grew its position in shares of Itron by 2.7% during the 1st quarter. Invesco Ltd. now owns 2,310,769 shares of the scientific and technical instruments company's stock worth $242,076,000 after buying an additional 59,962 shares during the period. Amundi lifted its stake in Itron by 18.4% in the first quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company's stock valued at $97,313,000 after buying an additional 144,361 shares in the last quarter. First Trust Advisors LP lifted its stake in Itron by 9.1% in the fourth quarter. First Trust Advisors LP now owns 802,584 shares of the scientific and technical instruments company's stock valued at $87,145,000 after buying an additional 66,637 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Itron by 129.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 732,274 shares of the scientific and technical instruments company's stock worth $76,713,000 after purchasing an additional 413,487 shares in the last quarter. Finally, Norges Bank bought a new stake in shares of Itron in the fourth quarter worth $64,615,000. 96.19% of the stock is owned by institutional investors.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.